Cognitive Function After Stem Cell Transplantation
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The trial will evaluate the effects of an exercise program on the physical and cognitive performance of patients with hematological neoplastic diseases after high dose chemotherapy with stem cell support.
Full description
Patients (n = 60) will be randomized to an exercise or a control group. The randomization will be stratified for allogeneic or autologous blood stem cell transplantation. Patients in the exercise group will carry out an endurance training consisting of walking on a treadmill at a speed corresponding to 80% of the maximum heart rate. The exercise program will be carried out 3 times weekly for 8 weeks. Patients in the control group will receive counseling about exercise and behavioural techniques to reduce fatigue, but they will not participate at a structured exercise program. Physical performance (VO2max), cognitive function, mood and quality of life will be evaluated at recruitment and after 8 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age 18 - 70
- Hematological neoplastic disease
- Treatment with high-dose chemotherapy with peripheral blood stem cell transplantation in the previous 3 years
- Karnofsky-Index > 80%
- Ability to understand German
Exclusion criteria
- Cardiorespiratory, metabolic, inflammatory or osteoarticular diseases which can be aggravated by exercise
- Psychosis
- Organic brain damage
- Dementia
- PBSCT in the previous 6 weeks
- Pathological stress test at admission
Trial design
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Fernando Dimeo, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal